Biologic Abatement and Capturing Kids' Outcomes and Flare Frequency in Juvenile Spondyloarthritis (BACK OFF JSpA)
Primary Objective
Aim 1. To compare the likelihood of disease flare associated with fixed standard dosing, fixed longer dosing intervals, or stopping TNFi in children with spondyloarthritis who have inactive disease. Aim 2. To compare patients lived experiences in the three treatment arms (Standard dosing TNFi, Tapered dosing TNFi, and TNFi withdrawal).
Details
Age
Child to Adult
Type of Study
Treatment
Scope
National
Locations
Childrens Hospital Colorado
Principal Investigator
Jennifer Cooper, MD
Study ID
Protocol Number: 21-4033
More information available at ClinicalTrials.gov: NCT04891640
Is this Study for You?
Not finding the right Study for you? Join ResearchMatch, a nation-wide registry connecting volunteers and researchers